Literature DB >> 23354692

In-vitro analysis of the effect of gentamicin and polyhexanide on bone tissue.

Hans-Jürgen Kock1, Dirk Ernst, Frank Jethon, Werner Fabry.   

Abstract

PURPOSE: Though anti-infectives have been used for a long time in surgical procedures, the effect on bone tissue has not been determined for most antibiotics and antiseptics.
METHODS: In our in vitro study, 4x4x8 mm(3) blocks of rabbit cancellous bone tissue were incubated with Ringer's solution, gentamicin and Lavasorb(®) each for time intervals of 15 minutes, 30 minutes, one hour, four hours and eight hours. Samples were examined double blinded through optical and electron microscopy.
RESULTS: Tissue degeneration was observed in all samples. It was low in Ringer's solution. Samples with Lavasorb showed a moderate degeneration after 15 and 30 minutes, which was accelerated after one hour. Gentamicin led to a moderate degeneration of bone tissue after 15 and 30 minutes and to a more accelerated degeneration after one hour. The effect of gentamicin on bone tissue was more pronounced than the effect of Lavasorb.
CONCLUSIONS: This investigation showed that local application of Lavasorb or gentamicin on bone tissue should be restricted to 30 minutes, while Lavasorb showed a better tissue tolerability. This finding could have clinical implications for the management of wounds with open osseous tissue and should be further investigated by in vivo studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354692      PMCID: PMC3609983          DOI: 10.1007/s00264-013-1786-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  15 in total

1.  [Effectiveness of an improved antiseptic in treatment of contaminated soft tissue wounds].

Authors:  K P Schmit-Neuerburg; C Bettag; W Schlickewei; W Fabry; J Hanke; K Renzing-Köhler; H Hirche; H J Kock
Journal:  Chirurg       Date:  2001-01       Impact factor: 0.955

2.  [Preventive intraoperative irrigation in wound management with Lavasept. Report of experiences with 1,610 cases].

Authors:  B Roth; K Baltzer
Journal:  Z Unfallchir Versicherungsmed       Date:  1990

Review 3.  Reducing the risk of deep wound infection in primary joint arthroplasty with antibiotic bone cement.

Authors:  Jon E Block; Harrison A Stubbs
Journal:  Orthopedics       Date:  2005-11       Impact factor: 1.390

Review 4.  Local antibiotic therapy in the treatment of open fractures and osteomyelitis.

Authors:  Charalampos G Zalavras; Michael J Patzakis; Paul Holtom
Journal:  Clin Orthop Relat Res       Date:  2004-10       Impact factor: 4.176

5.  [Storage-induced changes in autologous spongioid bone].

Authors:  U Drenhaus; M Imhoff; H Tassler
Journal:  Unfallchirurg       Date:  1988-04       Impact factor: 1.000

6.  Effects of gentamicin and monomer on bone. An in vitro study.

Authors:  J G Pedersen; B Lund
Journal:  J Arthroplasty       Date:  1988       Impact factor: 4.757

7.  Osteogenesis in bone grafts after short-term storage and topical antibiotic treatment. An experimental study in rats.

Authors:  J C Gray; M W Elves
Journal:  J Bone Joint Surg Br       Date:  1981

8.  [Intraoperative wound irrigation with a new local antiseptic].

Authors:  B Roth; J Müller; H Willenegger
Journal:  Helv Chir Acta       Date:  1985-04

9.  [Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model].

Authors:  H J Kock; S Werther; H Uhlenkott; G Taeger
Journal:  Unfallchirurg       Date:  2002-09       Impact factor: 1.000

10.  Locally administered antibiotics for prophylaxis against surgical wound infection. An in vivo study.

Authors:  Seth R Yarboro; Elyse J Baum; Laurence E Dahners
Journal:  J Bone Joint Surg Am       Date:  2007-05       Impact factor: 5.284

View more
  1 in total

1.  Human osteoblast damage after antiseptic treatment.

Authors:  Pauline Vörös; Oliver Dobrindt; Carsten Perka; Christoph Windisch; Georg Matziolis; Eric Röhner
Journal:  Int Orthop       Date:  2014-01       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.